Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Usp36em1/Cya
Common Name:
Usp36-KO
Product ID:
S-KO-18222
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Usp36-KO
Strain ID
KOCMP-72344-Usp36-B6J-VB
Gene Name
Usp36
Product ID
S-KO-18222
Gene Alias
2700002L06Rik; mKIAA1453
Background
C57BL/6JCya
NCBI ID
72344
Modification
Conventional knockout
Chromosome
11
Phenotype
MGI:1919594
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Usp36em1/Cya mice (Catalog S-KO-18222) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000092382
NCBI RefSeq
NM_001033528
Target Region
Exon 5~6
Size of Effective Region
~2.0 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Usp36, a member of the USP family of deubiquitinating enzymes, plays a crucial role in the balance between ubiquitination and deubiquitination, hydrolyzing and removing ubiquitin chains from target proteins. It is involved in various cellular events such as gene transcription regulation, cell cycle regulation, and immune responses, which are essential for maintaining cellular homeostasis [8].

In cancer, Usp36 has been implicated in promoting tumorigenesis and drug resistance. In breast cancer, it deubiquitinates and stabilizes ERα, promoting tumorigenesis and tamoxifen resistance [2]. In colorectal cancer, Usp36 inhibits apoptosis by deubiquitinating cIAP1 and survivin, and promotes cancer progression by inhibiting the p53 signaling pathway via stabilizing RBM28 [3,4]. In glioblastoma, it deubiquitinates and stabilizes ALKBH5, promoting tumorigenesis and affecting drug sensitivity [5]. In esophageal squamous carcinoma, USP36 stabilizes YAP to facilitate cancer progression [6]. Also, in non-small cell lung cancer, a germline USP36 mutation confers resistance to EGFR-TKIs by upregulating MLLT3 expression [10]. Additionally, in doxorubicin-induced cardiomyopathy, Dox promotes disease progression by activating USP36-mediated PARP1 deubiquitination [7]. In ribosome biogenesis, USP36 acts as a SUMO ligase to promote EXOSC10 SUMOylation, which is critical for the RNA exosome function in rRNA processing [9]. In solid tumors, ribotoxic stress activates the JNK-USP36 signaling to stabilize Snail1 in the nucleolus, facilitating ribosome biogenesis and tumor cell survival, and contributing to resistance to the ribosome inhibitor homoharringtonine (HHT) [1].

In conclusion, Usp36 is a multifunctional deubiquitinating enzyme with significant implications in cancer and other diseases. Studies using in vivo models such as xenograft models in breast cancer [2] and intracranial tumor growth assays in glioblastoma [5] have helped reveal its role in promoting tumorigenesis and drug resistance. These findings suggest that targeting Usp36 could be a potential therapeutic strategy for treating related diseases.

References:
1. Qin, Kewei, Yu, Shuhan, Liu, Yang, Xiao, Zhi-Xiong Jim, Yi, Yong. 2023. USP36 stabilizes nucleolar Snail1 to promote ribosome biogenesis and cancer cell survival upon ribotoxic stress. In Nature communications, 14, 6473. doi:10.1038/s41467-023-42257-8. https://pubmed.ncbi.nlm.nih.gov/37833415/
2. Zhuang, Ting, Zhang, Shuqing, Liu, Dongyi, Zhu, Jian, Yang, Huijie. 2024. USP36 promotes tumorigenesis and tamoxifen resistance in breast cancer by deubiquitinating and stabilizing ERα. In Journal of experimental & clinical cancer research : CR, 43, 249. doi:10.1186/s13046-024-03160-2. https://pubmed.ncbi.nlm.nih.gov/39215346/
3. Gao, Bao, Qiao, Yuan, Zhu, Shan, Liu, Yong-Jun, Chen, Jingtao. 2024. USP36 inhibits apoptosis by deubiquitinating cIAP1 and survivin in colorectal cancer cells. In The Journal of biological chemistry, 300, 107463. doi:10.1016/j.jbc.2024.107463. https://pubmed.ncbi.nlm.nih.gov/38876304/
4. Xu, Hengjie, Wang, Tuo, Nie, Hongxu, Feng, Yifei, Sun, Yueming. 2024. USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28. In Oncogene, 43, 3442-3455. doi:10.1038/s41388-024-03178-y. https://pubmed.ncbi.nlm.nih.gov/39343961/
5. Chang, Guoqiang, Xie, Gloria S, Ma, Li, Li, Linlin, Richard, Hope T. . USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5. In Neuro-oncology, 25, 841-853. doi:10.1093/neuonc/noac238. https://pubmed.ncbi.nlm.nih.gov/36239338/
6. Zhang, Wenhao, Luo, Junwen, Xiao, Zhaohua, Zhu, Jian, Zhao, Xiaogang. 2022. USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP. In Cell death & disease, 13, 1021. doi:10.1038/s41419-022-05474-5. https://pubmed.ncbi.nlm.nih.gov/36470870/
7. Wang, Dongchen, Jiang, Zihao, Kan, Junyan, Zhu, Linlin, Gu, Yue. 2024. USP36-mediated PARP1 deubiquitination in doxorubicin-induced cardiomyopathy. In Cellular signalling, 117, 111070. doi:10.1016/j.cellsig.2024.111070. https://pubmed.ncbi.nlm.nih.gov/38307305/
8. Niu, Meng-Yao, Liu, Yan-Jun, Shi, Jin-Jin, Yang, Guan-Jun, Chen, Jiong. 2024. The Emerging Role of Ubiquitin-Specific Protease 36 (USP36) in Cancer and Beyond. In Biomolecules, 14, . doi:10.3390/biom14050572. https://pubmed.ncbi.nlm.nih.gov/38785979/
9. Chen, Yingxiao, Li, Yanping, Dai, Roselyn S, Sun, Xiao-Xin, Dai, Mu-Shui. . The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing. In Nucleic acids research, 51, 3934-3949. doi:10.1093/nar/gkad140. https://pubmed.ncbi.nlm.nih.gov/36912080/
10. Guan, Shaoxing, Chen, Xi, Wei, Yuru, Wang, Xueding, Zhang, Li. . Germline USP36 Mutation Confers Resistance to EGFR-TKIs by Upregulating MLLT3 Expression in Patients with Non-Small Cell Lung Cancer. In Clinical cancer research : an official journal of the American Association for Cancer Research, 30, 1382-1396. doi:10.1158/1078-0432.CCR-23-2357. https://pubmed.ncbi.nlm.nih.gov/38261467/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest